Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
---|
01/22/1992 | EP0466769A1 Reducing post-prandial plasma large neutral amino acid concentrations. |
01/22/1992 | EP0336950B1 Potentiation of antihypertensive effect of ace inhibitors |
01/21/1992 | CA2044855A1 Method for treating insult to neurons prone to parkinson's degeneration employing an atp-sensitive potassium channel blocker |
01/21/1992 | CA1294548C2 Dehydrated liposomes |
01/20/1992 | CA2044854A1 Method for preventing or treating urinary incontinence |
01/15/1992 | EP0466650A2 Improvements in non-steroidal anti-inflammatory therapy |
01/15/1992 | EP0465588A1 The use of liposomes for the delivery of therapeutic agents to wounds, cuts and abrasions |
01/15/1992 | EP0465583A1 Use of a potassic agonist in the treatment of glaucoma |
01/15/1992 | EP0372070A4 Method for making solvent dilution microcarriers |
01/14/1992 | WO1992000988A1 Targeted drug delivery via phosphonate derivatives |
01/14/1992 | US5081148 Blocking agents of edrf effect or formation for the treatment of shock |
01/14/1992 | CA2087194A1 Targeted drug delivery via phosphonate derivatives |
01/12/1992 | CA2046677A1 Non-steroidal anti-inflammatory therapy |
01/09/1992 | WO1992000330A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
01/09/1992 | WO1992000329A1 Surface complexed lymphotoxin |
01/09/1992 | WO1992000103A1 Pharmaceutical preparations |
01/09/1992 | WO1992000071A1 Immunoregulatory agents |
01/09/1992 | WO1992000010A1 Method of treating human prostatic adenocarcinoma |
01/09/1992 | DE4020144A1 Patches for topical or transdermal drug delivery - with adhesive layer contg. polyacrylate adhesive and film former |
01/09/1992 | CA2084510A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
01/08/1992 | EP0465235A1 Pharmaceutical compositions and methods for alleviating gastrointestinal symptoms induced by nonsteroidal anti-inflammatory drugs |
01/08/1992 | EP0465234A1 Pharmaceutical compositions and methods for alleviating gastrointestinal distress symptoms induced by nonsteroidal anti-inflammatory drugs |
01/08/1992 | EP0465096A1 Plasma cholesterol level lowering composition |
01/08/1992 | EP0464573A1 Plaster high in softening substances |
01/08/1992 | EP0464137A1 Inhibition of hiv using synergistic combinations of nucleoside derivatives |
01/07/1992 | US5079253 Composition for the topical treatment of glaucoma or ocular hypertension |
01/04/1992 | CA2046079A1 Pharmaceutical compositions and methods for alleviating gastrointestinal distress symptoms induced by nonsteroidal anti-inflammatory drugs |
01/04/1992 | CA2046074A1 Pharmaceutical compositions and methods for alleviating gastrointestinal symptoms induced by nonsteroidal anti-inflammatory drugs |
01/02/1992 | EP0463653A1 Galenic formulations containing cyclodextrins |
01/02/1992 | EP0463560A1 New antiepileptic agents |
01/02/1992 | EP0439513A4 Composition for inhibiting transmission of aids |
01/01/1992 | CN1057462A Aminobenzodiazepine |
12/31/1991 | US5077055 Topical therapeutic system comprising 5-fluorouracil |
12/27/1991 | EP0462631A1 Methods and compositions for the treatment of gastrointestinal disorders |
12/27/1991 | EP0462549A1 Process of preparing a therapeutic agent for renal diseases |
12/27/1991 | EP0462522A1 Aminobenzodiazepines |
12/27/1991 | CA2045428A1 Method for enhancing the lowering of plasma cholesterol levels |
12/26/1991 | WO1991016045A3 Use of 5-ht4 receptor antagonists in the treatment of arrythmias and stroke |
12/24/1991 | US5075302 Treating hypertension, congestive heart failure |
12/24/1991 | US5075109 Administering in encapsulated form |
12/23/1991 | WO1992000102A1 Novel treatment |
12/23/1991 | CA2085873A1 Treatment |
12/19/1991 | WO1991019493A1 Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex |
12/19/1991 | CA2044694A1 Aminobenzodiazepines |
12/18/1991 | EP0461548A2 Method for preventing a second heart attack employing and HMG CoA reductase inhibitor |
12/18/1991 | EP0461530A2 Synergistic antimicrobial compositions |
12/17/1991 | US5073539 Transdermal administration of zwitterionic drugs |
12/17/1991 | US5073374 Drug delivery with active material, water soluble excipient an d lubricant |
12/14/1991 | CA2043463A1 Synergistic antimicrobial compositions |
12/12/1991 | WO1991019498A1 Treatment of organ transplantation rejection |
12/12/1991 | WO1991018608A1 Use of platelet activating factor antagonists as anti-pruritic agents |
12/12/1991 | WO1991018591A1 Inhibition of viral infection |
12/12/1991 | WO1991000081A3 Anti-malarial composition and method of use |
12/12/1991 | CA2085002A1 Treatment of organ transplantation rejection |
12/12/1991 | CA2083611A1 Use of platelet activating factor antagonists as anti-pruritic agents |
12/12/1991 | CA2042526A1 Method for preventing a second heart attack employing an hmg coa reductase inhibitor |
12/11/1991 | EP0460720A2 A method of extruding liposomes |
12/11/1991 | EP0460078A1 Pharmaceutically active agents that impede amyloid formation in vivo |
12/10/1991 | US5071643 Solvent system enhancing the solubility of pharmaceuticals for encapsulation |
12/07/1991 | WO1991018617A1 Immunostimulant drug based on polar glycopeptidolipids of mycobacterium chelonae |
12/05/1991 | DE4017439A1 New PEG ether or ester derivs. of tumour active or diagnostic agents - with longer in vivo lifetime and high levels in tumours, for nuclear medicine, chemotherapy, fluorescent diagnosis of photo-dynamic therapy |
12/04/1991 | EP0459453A2 Use of pravastatin for preventing onset of restenosis after angioplasty |
12/04/1991 | EP0459318A2 Method for preventing onset of restenosis after angioplasty employing an ACE inhibitor |
12/04/1991 | EP0458965A1 Process for the preparation of vinyl ethers. |
12/04/1991 | EP0458911A1 ENDOTHELIAL CELL-LEUKOCYTE ADHESION MOLECULES (ELAMs) AND MOLECULES INVOLVED IN LEUKOCYTE ADHESION (MILAs) |
12/04/1991 | EP0458901A1 Inhibiting transformation of cells having elevated purine metabolic enzyme activity |
12/03/1991 | US5070102 Medicaments for the treatment of cerebral apoplexy |
12/03/1991 | US5070084 Adrenergic blocking agent |
12/03/1991 | US5069898 Hair enrichment composition and method of use |
12/03/1991 | CA1292697C Transdermal administration of amines |
12/01/1991 | CA2042159A1 Method for preventing onset of restenosis after angioplasty employing an ace inhibitor |
12/01/1991 | CA2041951A1 Method for preventing onset of restenosis after angioplasty employing pravastatin |
11/28/1991 | WO1991018089A1 Association between a human immunodeficiency virus-related retrovirus and sjogren's syndrome |
11/28/1991 | WO1991017770A1 Synergistic tumor therapy with combinations of biologically active anti-tumor antibodies and chemotherapy |
11/28/1991 | CA2083391A1 Synergistic tumor therapy with combinations of biologically active anti-tumor antibodies and chemotherapy |
11/27/1991 | EP0458590A1 Treatment of ocular hypertention with a synergistic combination |
11/27/1991 | EP0458589A1 Treatment of ocular hypertension with an ocular synergistic combination |
11/27/1991 | EP0458587A1 Synergistic combination for ophthalmic use |
11/27/1991 | CN1056426A Synergistic therapeutic composition and methods |
11/26/1991 | US5068233 Synergistic combination of azelastine and theophylline or azelastine and α-mimetics |
11/21/1991 | EP0457514A1 Method for preventing, stabilizing or causing regression of atherosclerosis employing a combination of a cholesterol lowering drug and an ace inhibitor |
11/21/1991 | EP0457295A2 Use of a modulator of protein phosphorylation in the treatment of amyloidosis associated with Alzheimer's disease |
11/21/1991 | EP0457127A2 Spermicidal coating |
11/21/1991 | EP0456792A1 IMPROVED SYSTEM FOR THE TRANSDERMAL APPLICATION OF PHARMACOLOGICALLY ACTIVE COMPOUNDS AT CONTROLLED pH |
11/19/1991 | US5066490 Protein crosslinking reagents cleavable within acidified intracellular vesicles |
11/19/1991 | US5066487 Antisudoral composition comprising dibasic aluminium salts of acylated amino acids |
11/19/1991 | US5066480 Treating pulmonary hypertension caused by protamine induced neutralization of heparin |
11/17/1991 | WO1991018593A1 Formula and method for the prevention and treatment of hypercholesterolemia and cellular hyperproliferative disorders |
11/17/1991 | CA2080818A1 Formula and method for the prevention and treatment of hypercholesterolemia and cellular hyerproliferative disorders |
11/16/1991 | CA2042333A1 Spermicidal coating composition |
11/14/1991 | WO1991017174A1 Dna encoding human 5-ht1d receptors and uses thereof |
11/14/1991 | WO1991017159A1 1,3-oxathiolane nucleoside analogues |
11/14/1991 | WO1991016885A1 Dosage form to deliver an antiparkinson agent |
11/14/1991 | CA2374571A1 Dna encoding human 5-ht1d receptors and uses thereof |
11/14/1991 | CA2337748A1 1,3-oxathiolane nucleoside analogues |
11/12/1991 | WO1991018014A1 Anti-viral therapy |
11/12/1991 | WO1991017771A1 Synergistic therapeutic compositions and methods |
11/12/1991 | US5064571 Mixtures of fatty amido-amines from polyoxyalkyleneamines |
11/11/1991 | WO1991016903A2 Use of purine derivatives for anesthesia, analgesia and in vivo organ preservation |
11/06/1991 | EP0455510A2 Use of 5-HT1A receptor agonist compounds for inhibiting gastric acid secretion |